Repurposing of FDA-approved drugs against cancer – focus on metastasis
Béla Ozsvári1,
,
Rebecca Lamb1,
,
Michael P. Lisanti1,
,
-
1 The Breast Cancer Now Research Unit, Institute of Cancer Sciences, CRUK Manchester Institute, University of Manchester, UK
Received: February 9, 2016
Published: April 2, 2016
https://doi.org/10.18632/aging.100941
How to Cite
Cite this Article
How to cite
Ozsvári B, Lamb R, Lisanti MP, . Repurposing of FDA-approved drugs against cancer – focus on metastasis. Aging (Albany NY). 2016 Apr 2;
8:567-568
.
https://doi.org/10.18632/aging.100941
Copy or Download citation:
Select the format you require from the list below
Click to copy this citation from the text box above or download the citation:
Citation |
Citation & Abstract
Copyright: © 2016 Ozsvári et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
